Lexicon Pharmaceuticals to Participate in December Investor Conferences

Group 1 - Lexicon Pharmaceuticals will present at two investor conferences in December 2024, including the Piper Sandler 36th Annual Healthcare Conference on December 3 and the 7th Annual Evercore HealthCONx Conference on December 5 [1] - The presentations will be available via simultaneous webcasts on Lexicon's website, with recordings accessible for two weeks post-event [1] Group 2 - Lexicon Pharmaceuticals is a biopharmaceutical company focused on pioneering medicines that transform patients' lives [2] - The company utilizes its Genome5000™ program to study nearly 5,000 genes, identifying over 100 protein targets with significant therapeutic potential across various diseases [2] - Lexicon has a pipeline of drug candidates in discovery and clinical development targeting neuropathic pain, hypertrophic cardiomyopathy, obesity, metabolism, and other indications [2]